methyl 3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl}-3-oxopropanoate
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

methyl 3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl}-3-oxopropanoate

● In Stock

Catalogue No.:VE009200
CAS No.:N/A
Mol. Formula:C16H23NO5
Mol. Weight:309.36 g/mol

Additional information on methyl 3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl}-3-oxopropanoate

Parent drug

Metoprolol

IUPAC Name

methyl 3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl}-3-oxopropanoate

Synonyms

N/A

Description

methyl 3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl}-3-oxopropanoate or methyl 3-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl}-3-oxopropanoate, Metoprolol Impurities is an impurity of Metoprolol, it is a cardioselective beta-1-adrenergic receptor inhibitor that used to treat angina, heart failure, myocardial infarction, atrial fibrillation, and main hypertension, decreased cardiac excitability, cardiac output, and myocardial oxygen demand, it has succinate and tartrate derivatives, lower systemic bioavailability. it acts as to inhibition and decreases cardiac output by producing negative chronotropic.

References

Morris, Jason, and Alexis Dunham. “Metoprolol.” Nih.gov, StatPearls Publishing, 19 Jan. 2022, www.ncbi.nlm.nih.gov/books/NBK532923/. ‌

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url